BP
PHI icon

Ballentine Partners’s PLDT PHI Stock Holding History

Ballentine Partners’s Portfolio PHI Stock Details PHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Sell
11,166
-4,825
-30% -$93.4K ﹤0.01% 1014
2026
Q1 		$336K Buy
15,991
+3,811
+31% +$86.1K ﹤0.01% 685
2025
Q4 		$265K Buy
+12,180
New +$250K ﹤0.01% 775
2025
Q3 		– Sell
-12,769
Closed -$278K – 1054
2025
Q2 		$278K Sell
12,769
-1,731
-12% -$39.1K ﹤0.01% 719
2025
Q1 		$317K Buy
14,500
+52
+0.4% +$1.2K 0.01% 605
2024
Q4 		$320K Buy
14,448
+1,610
+13% +$38.2K 0.01% 573
2024
Q3 		$345K Buy
12,838
+826
+7% +$22K 0.01% 540
2024
Q2 		$295K Sell
12,012
-2,570
-18% -$62K 0.01% 568
2024
Q1 		$360K Buy
14,582
+2,753
+23% +$64.3K 0.01% 486
2023
Q4 		$277K Buy
+11,829
New +$265K 0.01% 523

Other funds holding PHI

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ballentine Partners's PHI Position: Q2 2026 in Review

Ballentine Partners reduced its PLDT (PHI) stake by 30% in Q2 2026, selling an estimated $93.4K and leaving 11,166 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

Ballentine Partners first reported a position in PHI in Q4 2023 and has held it in 10 quarters since. The position peaked at $360K in Q1 2024. 100 funds tracked by Wall St. Rank hold PHI as of Q2 2026.

  • Ballentine Partners held 11,166 shares of PLDT worth $196K as of Q2 2026.
  • Ballentine Partners sold 4,825 PLDT shares in Q2 2026, an estimated $93.4K.
  • PLDT made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #1014 holding.
  • Ballentine Partners first reported a position in PLDT in Q4 2023 and has held it in 10 quarters since.
  • Ballentine Partners's PLDT position peaked at $360K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held PLDT as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.